Ventilator-associated respiratory infection following lung transplantation

European Respiratory Journal

Volumn 45, Issue 3, 2015, Pages 726-737

  Riera, Jordi ^a   Caralt, Berta ^a   López, Iker ^a   Augustin, Salvador ^a   Roman, Antonio ^a,b   Gavalda, Joan ^a,c   Rello, Jordi ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFEPIME; CEFTAZIDIME; COLISTIN; IMMUNOGLOBULIN; MEROPENEM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PIPERACILLIN PLUS TAZOBACTAM; RITUXIMAB; TACROLIMUS; TUBERCULOSTATIC AGENT; ANTIINFECTIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; AGED; ANTIBODY MEDIATED REJECTION; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DRUG MEGADOSE; ENTEROBACTERIACEAE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; LENGTH OF STAY; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MEDICAL RECORD REVIEW; MIDDLE AGED; MORTALITY; PLASMAPHERESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; STOMACH PARESIS; SURVIVAL RATE; TRACHEOBRONCHITIS; VENTILATOR ASSOCIATED PNEUMONIA; VENTILATOR ASSOCIATED TRACHEOBRONCHITIS; YOUNG ADULT; ADVERSE EFFECTS; COMPLICATION; ENTEROBACTERIACEAE INFECTIONS; GASTROPARESIS; OUTCOME ASSESSMENT; PNEUMONIA, VENTILATOR-ASSOCIATED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDY; SPAIN;

ANTI-BACTERIAL AGENTS; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GASTROPARESIS; HOSPITAL MORTALITY; HUMANS; INCIDENCE; LENGTH OF STAY; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA, VENTILATOR-ASSOCIATED; POSTOPERATIVE COMPLICATIONS; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 84923878419     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00095214     Document Type: Article

References (40)

1. Hosenpud JD, Bennett LE, Keck BM, et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351: 24-27.
2. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614.
3. Aguilar-Guisado M, Givaldá J, Ussetti P, et al. Pneumonia after lung transplantation in the RESITRA cohort: a multi-center prospective study. Am J Transplant 2007; 7: 1989-1996.
4. Reid KR, McKenzie FN, Menkis AH, et al. Importance of chronic aspiration in recipients of heart-lung transplants. Lancet 1990; 336: 206-208.
5. Robertson AG, Krishnan A, Ward C, et al. Anti-reflux surgery in lung transplant recipients: outcomes and effects on quality of life. Eur Respir J 2012; 39: 691-697.
6. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report - 2012. J Heart Lung Transplant 2012; 31: 1073-1086.
7. Lockhart SR, Abramson MA, Beekmann SE, et al. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 2007; 45: 3352-3359.
8. Deusch E, End A, Grimm M, et al. Early bacterial infections in lung transplant recipients. Chest 1993; 104: 1412-1416.
9. Mattner F, Fischer S, Weissbrodt H, et al. Post-operative nosocomial infections after lung and heart transplantation. J Heart Lung Transplant 2007; 26: 241-249.
10. Dudau D, Camous J, Marchand S, et al. Incidence of nosocomial pneumonia and risk of recurrence after antimicrobial therapy in critically ill lung and heart-lung transplant patients. Clin Transplant 2014; 28: 27-36.
11. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
12. Palmer LB, Smaldone GC, Chen JJ, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008; 36: 2008-2013.
13. Paterson DL. The epidemiological profile of infections with multidrugresistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43 Suppl. 2:543-548.
14. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-166.
15. Matamis D, Soilemezi E, Tsagourias M, et al. Sonographic evaluation of the diaphragm in critically ill patients: technique and clinical applications. Intensive Care Med 2013; 39: 801-810.
16. Mentec H, Dupont H, Bocchetti M, et al. Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med 2001; 29: 1955-1961.
17. Díaz-Ravetllat V, Greer M, Haverich A, et al. Significance of new lung infiltrates in outpatients after lung and heart-lung transplantation. Transpl Infect Dis 2014; 16: 359-368.
18. Craven DE, Lei Y, Ruthazer R, et al. Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia. Am J Med 2013; 126: 542-549.
19. Bekaert M, Timsit JF, Vansteelandt S, et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 2011; 184: 1133-1139.
20. Melsen WG, Rovers MM, Groenwold RH, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 2013; 13: 665-671.
21. Stevens JP, Kachniarz B, Wright SB, et al. When policy gets it right: variability in U.S. hospitals' diagnosis of ventilator-associated pneumonia. Crit Care Med 2014; 42: 497-503.
22. Husain S, Mooney ML, Danziger-Isakov L, et al. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant 2011; 30: 361-374.
23. Shahin J, Bielinski M, Guichon C, et al. Suspected ventilator-associated respiratory infection in severely ill patients: a prospective observational study. Crit Care 2013; 17: R251.
24. Nseir S, Di Pompeo C, Soubrier S, et al. Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control study. Crit Care 2005; 9: R238-R245.
25. Husain S, Chan KM, Palmer SM, et al. Bacteremia in lung transplant recipients in the current era. Am J Transplant 2006; 6: 3000-3007.
26. Berkowitz N, Schulman LL, McGregor C, et al. Gastroparesis after lung transplantation. Potential role in postoperative respiratory complications. Chest 1995; 108: 1602-1607.
27. Smith PC, Slaughter MS, Petty MG, et al. Abdominal complications after lung transplantation. J Heart Lung Transplant 1995; 14: 44-51.
28. Basseri B, Conklin JL, Pimentel M, et al. Esophageal motor dysfunction and gastroesophageal reflux are prevalent in lung transplant candidates. Ann Thorac Surg 2010; 90: 1630-1636.
29. Hadjiliadis D, Duane Davis R, Steele MP, et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003; 17: 363-368.
30. Blondeau K, Mertens V, Vanaudenaerde BA, et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 2008; 31: 707-713.
31. Cantu E 3rd, Appel JZ 3rd, Hartwig MG, et al. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004; 78: 1142-1151.
32. Abbassi-Ghadi N, Kumar S, Cheung B, et al. Anti-reflux surgery for lung transplant recipients in the presence of impedance-detected duodenogastroesophageal reflux and bronchiolitis obliterans syndrome: a study of efficacy and safety. J Heart Lung Transplant 2013; 32: 588-595.
33. Akindipe OA, Faul JL, Vierra MA, et al. The surgical management of severe gastroparesis in heart/lung transplant recipients. Chest 2000; 117: 907-910.
34. Augustine SM, Yeo CJ, Buchman TG, et al. Gastrointestinal complications in heart and in heart-lung transplant patients. J Heart Lung Transplant 1991; 10: 547-555.
35. Vos R, Blondeau K, Vanaudenaerde BM, et al. Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together? J Heart Lung Transplant 2008; 27: 843-849.
36. Sheridan PH Jr, Cheriyan A, Doud J, et al. Incidence of phrenic neuropathy after isolated lung transplantation. The Loyola University Lung Transplant Group. J Heart Lung Transplant 1995; 14: 684-691.
37. Ferdinande P, Bruyninckx F, Van Raemdonck D, et al. Phrenic nerve dysfunction after heart-lung and lung transplantation. J Heart Lung Transplant 2004; 23: 105-109.
38. Bonde PN, Patel ND, Borja MC, et al. Impact of donor lung organisms on post-lung transplant pneumonia. J Heart Lung Transplant 2006; 25: 99-105.
39. Suhling H, Rademacher J, Greer M, et al. Inhaled colistin following lung transplantation in colonised cystic fibrosis patients. Eur Respir J 2013; 42: 542-544.
40. Hayat JO, Gabieta-Somnez S, Yazaki E, et al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut 2014 [In press DOI: 10.1136/gutjnl-2014-307049].